Skip to main content
Premium Trial:

Request an Annual Quote

Lexicon Reports Weak Q3 Revenues, Surging Loss

NEW YORK, Oct. 31 - Lexicon Genetics yesterday reported a significant fall in total third-quarter revenue atop a strong jump in R&D spending and a surge in net loss.


Revenues for the period ended Sept. 30 were $8 million, compared with $13.5 million during the same quarter one year ago, Lexicon said .


R&D spending in the quarter increased to $19.8 million from $15 million one year ago.


As a result, net loss ballooned to $16.8 million, or $.32 per share, from $6.2 million, or $.12 per share, in the third quarter 2001, the company said.


Lexicon Genetics said it had roughly $119.6 million in cash and investments as of Sept. 30.


Click here for more information.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.